Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in ​its largest deal since 2020, the ​biopharma company said on ​Monday.

Explore Canada's safest online casinos for 2026—trusted sites for real-money play, fast payouts, and top bonuses. See our top ...

Austria’s financial regulator has prohibited KuCoin EU Exchange from conducting new business, citing breaches of internal organizational requirements around Anti-Money Laundering (AML), ...

Nigeria's struggle with corruption seemingly remains stubbornly unresolved, despite years of reforms, prosecutions and policy pledges. The 2025 Corruption Perceptions Index (CPI) recently released by ...

AbbVie announces US FDA approves combination treatment of Venclexta and acalabrutinib for previously untreated patients with CLL: North Chicago, Illinois Monday, February 23, 2026 ...

With Arcellx, Gilead gains proprietary technology and a platform for future cell therapies. The acquisition strengthens its ...

Xona Systems today announced Platform v5.5, a secure access solution designed to address the convergence of escalating threats, tightening regulatory requirements, and operational realities that ...

Gilead Sciences, Inc. today announced that it has entered into a definitive agreement to acquire Arcellx for $115 per share in cash at closing and one contingent value right of $5 per share, which ...

Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...

Canada’s digital economy has been growing at a rapid pace, putting pressure on entertainment platforms on matters of security ...

Like Rett syndrome, Pitt Hopkins syndrome is a rare neurodevelopmental disorder, though it doesn’t involve regression.

AML Incubator (AMLI) today announced the launch of its Audit-Ready AML Readiness Program, a structured remediation and implementation ...